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The United States’ health care system is experiencing remarkable change.
The Patient Protection and Affordable Care Act—and its subsequent revisions
—reshaped insurance for millions of Americans (Courtemanche et al. 2017).
The Affordable Care Act also introduced myriad payment reforms to improve
quality and value (Zuckerman et al. 2016). Within commercial insurance, pro-
vider consolidation (Post, Buchmueller, and Ryan 2018) and experiments with
reference pricing (Robinson and Brown 2013) are having potentially profound
effects on health care prices.
These remarkable changes demand evaluation. Difference-in-differ-
ences has emerged as the key strategy to evaluate changes in health care.
These methods are intuitive, simple, and relatively easy to implement (Angrist
and Pischke 2010). This, coupled with researchers’ increasing access to rich
datasets and enhanced computing power, has led to an explosion in the use of
difference-in-differences as a tool to evaluate programs and policy.
This is a welcome development. Yet despite its widespread adoption,
major issues related to specification of difference-in-differences have gone
unresolved. Chief among them is the choice of comparison group. Research-
ers require a comparison group, not exposed to the target intervention, to
serve as the counterfactual for the treated group. One option for the compar-
ison group is all untreated units. Yet the treated units and comparison units
may be meaningfully different, either with respect to the study outcomes or
covariates related to the outcomes. Outcomes for the treated and comparison
groups may also not be “parallel” prior to the start of the intervention. Parallel
trends are often considered to be the key assumption underlying the validity
of difference-in-differences.





In the face of these challenges, researchers may opt to select a subset of
untreated units as a more appropriate comparison group. For instance, a study
ofMedicaid expansion prior to the Affordable Care Act identified comparison
states as those that neighbored expansion states and were most similar with
respect to population and demographic characteristics (Sommers, Katherine,
and Epstein 2012). Alternatively, researchers may choose to explicitly match
treated units to one or more comparison group on the basis of preintervention
levels in outcomes (O’Neill et al. 2016; Ryan et al. 2017), trends in outcomes,
or covariates thought to be relevant to outcomes (Werner et al. 2011; Figueroa
et al. 2016). The point of choosing a subset from the universe of untreated
units is the expectation that this subset may serve as a more appropriate coun-
terfactual. In other words, without the program or policy, the future outcomes
of this subset may be expected to change at the same rate as the treated group.
This brings us to this study. Daw and Hatfield perform a Monte Carlo
simulation study to assess the impact of matching on treatment effects in the
context of difference-in-differences (Daw andHatfield 2018). They evaluate dif-
ferences in bias across estimators that are unmatched, matched on covariates
that are related to the outcome, matched on preintervention levels of out-
comes, and matched on preintervention trends in outcomes. They also
explore bias under different scenarios related to the correlation between treat-
ment assignment and levels of preintervention outcomes, trends in preinter-
vention outcomes, and levels of covariates.
Daw and Hatfield find that matching tends to increase bias, rather than
decrease it. The bias introduced by matching is particularly severe when
matching is based on preintervention levels and a key assumption of difference-
in-differences is met (no correlation between treatment and outcome trend). In
these cases, bias increases with the difference in preintervention levels. This bias
is caused by mean reversion. Because the treatment and comparison groups are
drawn from different distributions, any observed overlap in outcomes between
the treatment and comparison groups is a result of noise. Matching on this noise
will not purge bias but rather will lead to mean reversion as the control group
returns to its natural mean in the postintervention period.
This is an extremely important, timely, and practical investigation. It
highlights a specification issue in difference-in-differences that has received
limited attention in the literature (Chay and McEwan 2005). By identifying
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the circumstances under which matching is most likely to lead to bias, it pro-
vides a practical guide to researchers.
Yet Daw and Hatfield identify a researcher error that is relatively nar-
row: a case where researchers try to solve a problem that does not exist. In
their study, the bias introduced by matching occurs when assumptions of dif-
ference-in-differences hold and researchers could derive an unbiased estimate
using standard methods. By matching treatment and control groups when
there is no need to do so, a research “self-own” is committed.
In practice, researchers often pursue matching when they have reason to
believe that assumptions in difference-in-differences do not hold. Specifically,
when preintervention trends are not parallel between treatment and compar-
ison groups, researchers worry that treatment assignment will be correlated
with future outcome trends. It is under these circumstances researchers may
attempt to use a subset of the comparison group (through matching or qualita-
tive selection of units) that could be a more appropriate counterfactual. When
Daw and Hatfield evaluate the scenario where treatment assignment is corre-
lated with preintervention trends (i.e., when a key assumption of difference-in-
differences is violated), they find that, while there is considerable bias for all
the estimators, matching on preintervention trends reduces bias (particularly
when the outcome is highly serially correlated).
Relatedly, in their simulation, Daw and Hatfield consider only the case
where the levels and trends for the treatment group are drawn from one distri-
bution, while the levels and trends for the comparison group are drawn from a
different distribution. In other words, there is no overlap in true distributions
between the treatment and comparison groups. There is only overlap between
the observed distributions. In practice, there is likely to be overlap in true
outcome distributions between treatment and comparison groups (e.g., a
high-performing academic medical center in treated state compared to a high-
performing academic medical center in neighboring comparison state).
Greater overlap between the true distributions of levels and trends would
likely decrease the problem associated with mean reversion. In such circum-
stances, matching has the potential to be beneficial if covariates, preinterven-
tion levels, and preintervention trends are correlated with future outcomes.
The performance of matching estimators in the context of difference-
in-differences has been evaluated in other simulation work. Our research team
performed a simulation analysis that started with real data on clinical process
performance from acute care hospitals in the United States. We assigned an
intervention to hospitals under different scenarios concerning the correlation
between treatment, preintervention levels of outcomes, and preintervention
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trends in outcomes. When treatment was correlated with preintervention
trends, our matching estimator—which matched on lagged levels for each of
the three preintervention periods—had substantially lower bias than the other
estimators examined, including standard difference-in-differences (Ryan, Bur-
gess, and Dimick 2015). In another study, O’Neil and colleagues specified a
simulation model to evaluate the performance of several estimators (including
the synthetic control method, a lagged dependent variable regression
approach, and matching on lagged outcomes) in the presence of parallel and
nonparallel trends in outcomes (O’Neill et al. 2016). They found that, when
trends in outcomes were parallel, the standard difference-in-differences esti-
mator was the most accurate. However, the matching estimator was reason-
ably accurate, particularly when a large number of preintervention periods
were available for matching. The authors also found that, when outcomes
trends were not parallel, the standard difference-in-differences estimator had
the greatest bias. Together, this work suggests that matching estimators can
outperform standard difference-in-differences under certain circumstances.
It is challenging to compare results across simulations. Yet one reason
why the matching estimator may have performed better in the studies by our
research team and O’Neil and colleagues is because these simulation models
were not constructed to include no overlap in true levels and trends between
the treatment and comparison groups.
Difference-in-differences is an essential tool to understand our changing
health care system. Daw and Hatfield highlight a case when statistical match-
ing can undermine difference-in-differences. Future research should continue
to develop, implement, and examine the properties of other new tools, such as
generalized synthetic control methods (Xu 2017), that can generate unbiased
estimates while relaxing the standard assumptions of difference-in-differences
analysis.
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